Wells Fargo Amends Emergent BioSolutions’ Credit Facility, Reducing Size to $200MM
Emergent BioSolutions entered into an amendment to its existing credit facility, reducing the amount of its revolving credit facility to $200 million in stages between now and Oct. 31, according to an 8K filed with the SEC. Wells Fargo is the administrative agent for the facility.
May 1, 2024
Emergent BioSolutions | wells fargo
Brianna Wilson